diminazene aceturate has been researched along with Glaucoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cardoso, VN; Faraco, AA; Fernandes, RS; Fernandes, SO; Ferreira, AJ; Foureaux, G; Franca, JR; Fulgêncio, GO; Menezes, GB; Nogueira, BS; Nogueira, JC; Oliveira, GP; Raizada, MK | 1 |
| Cardoso, VN; Castilho, RO; Cronemberger, S; Faraco, AA; Fernandes, SO; Ferreira, AJ; Foureaux, G; Franca, JR; Fulgêncio, Gde O; Fuscaldi, LL; Nogueira, JC; Ribeiro, TG; Yoshida, MI | 1 |
2 other study(ies) available for diminazene aceturate and Glaucoma
| Article | Year |
|---|---|
Antiglaucomatous effects of the activation of intrinsic Angiotensin-converting enzyme 2.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Aqueous Humor; Blood Pressure; Caspase 3; Cell Count; Diminazene; Disease Models, Animal; Enzyme Activation; Fluorescent Antibody Technique, Indirect; Glaucoma; Immunoenzyme Techniques; Intraocular Pressure; Male; Nerve Fibers; Ophthalmic Solutions; Optic Nerve; Peptide Fragments; Peptidyl-Dipeptidase A; Radionuclide Imaging; Rats; Rats, Wistar; Renin-Angiotensin System; Retina; Retinal Ganglion Cells; Sulfonamides; Thiophenes; Tonometry, Ocular | 2013 |
Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats.
Topics: Administration, Ophthalmic; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Calorimetry, Differential Scanning; Chitosan; Delayed-Action Preparations; Diminazene; Drug Evaluation, Preclinical; Enzyme Activation; Eye Proteins; Glaucoma; Hyaluronic Acid; Intraocular Pressure; Male; Microscopy, Electron, Scanning; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Spectroscopy, Fourier Transform Infrared; Tissue Distribution | 2015 |